[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100537222":3},{"organization":4,"armGroups":7,"interventions":30,"overallOfficials":43,"centralContacts":48,"locations":54,"responsibleParty":70,"collaborators":35,"id":74,"slug":35,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":35,"eligibilityCriteria":79,"healthyVolunteers":75,"sex":80,"minAge":81,"maxAge":82,"enrollmentInfo":83,"targetDuration":35,"studyType":86,"phases":87,"briefSummary":89,"conditions":90,"keywords":92,"overallStatus":57,"whyStopped":35,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":106},{"fullName":5,"class":6},"Nanjing Children's Hospital","OTHER",[8,14,20,25],{"label":9,"type":10,"description":11,"interventionNames":12},"Macro\u002Fmixed cystic lymphatic A","EXPERIMENTAL","Inflow occlusion assisted by indocyanine green-fluorescence imaging combined with perforation of septation and sclerotherapy",[13],"Procedure: Inflow occlusion with perforation of septation and sclerotherapy",{"label":15,"type":16,"description":17,"interventionNames":18},"Macro\u002Fmixed cystic lymphatic B","ACTIVE_COMPARATOR","Perforation of septation and sclerotherapy",[19],"Procedure: Perforation of septation and sclerotherapy",{"label":21,"type":10,"description":22,"interventionNames":23},"Microcystic lymphatic A","Indocyanine green-fluorescence imaging-guided partial resection and sclerotherapy",[24],"Procedure: Indocyanine green-guided partial resection and sclerotherapy",{"label":26,"type":16,"description":27,"interventionNames":28},"Microcystic lymphatic B","Partial resection and sclerotherapy",[29],"Procedure: Partial resection and sclerotherapy",[31,36,38,41],{"type":32,"name":33,"description":11,"armGroupLabels":34,"otherNames":35},"PROCEDURE","Inflow occlusion with perforation of septation and sclerotherapy",[9],null,{"type":32,"name":17,"description":17,"armGroupLabels":37,"otherNames":35},[15],{"type":32,"name":39,"description":22,"armGroupLabels":40,"otherNames":35},"Indocyanine green-guided partial resection and sclerotherapy",[21],{"type":32,"name":27,"description":27,"armGroupLabels":42,"otherNames":35},[26],[44],{"name":45,"affiliation":46,"role":47},"Weimin Shen, Dr.","Children's Hospital of Nanjing Medical University","STUDY_DIRECTOR",[49],{"name":50,"role":51,"phone":52,"phoneExt":35,"email":53},"Tao Han, Dr.","CONTACT","+86 186 5190 3495","dr.hantao@njmu.edu.cn",[55],{"facility":56,"status":57,"city":58,"state":59,"zip":60,"country":61,"cosmosGeoPoint":62,"geoPoint":67,"contacts":68},"Children's hospital of Nanjing medical university","RECRUITING","Nanjing","Jiangsu","210008","China",{"type":63,"coordinates":64},"Point",[65,66],118.77778,32.06167,{"lat":66,"lon":65},[69],{"name":50,"role":51,"phone":52,"phoneExt":35,"email":53},{"type":71,"investigatorFullName":72,"investigatorTitle":73,"investigatorAffiliation":5,"oldNameTitle":35,"oldOrganization":35},"PRINCIPAL_INVESTIGATOR","Tao Han","Dr.","100537222",false,"NCT06275022","A Prospective Study on the Treatment of cLM Based on ICG Imaging","A Prospective Randomized Controlled Study on the Treatment of Cystic Lymphatic Malformation Based on Indocyanine Green-fluorescence Imaging","Inclusion Criteria:\n\n(1) no previous intervention; (2) cLM diagnosed by pretreatment magnetic resonance imaging (MRI); (3)3 to 6 months post-treatment follow-up; (4) Superfacial cLM\n\nExclusion Criteria:\n\n(1) history of iodine allergy; (2) syndromic cLM ; (3) severe liver and kidney dysfunction; (4) intralesional hemorrhage; (5) intralesional infection","ALL","30 Days","16 Years",{"count":84,"type":85},110,"ESTIMATED","INTERVENTIONAL",[88],"NA","The goal of this prospective randomized controlled study is to explore the role of indocyanine green-fluorescence imaging in management of cystic lymphatic malformation.. To clarify the application value of indocyanine green-fluorescence imaging in both diagnosis and treatment of cystic lymphatic malformation (cLM) in children, is helpful for exploring pathogenesis of cLM, and providing a clearer scientific basis for subsequent surgical intervention. It also provides alternative for the future diagnosis and treatment of cLM.\n\nParticipants will receive indocyanine green-fluorescence imaging before operation, while the patients in control group will receive traditional operation.\n\nResearchers will compare difference in curative effect between two groups.",[91],"Lymphatic Malformation",[93,94,95,96],"indocyanine green","children","inflow","lymphography","2026-02-15",{"date":99,"type":100},"2026-02-18","ACTUAL",{"date":102,"type":100},"2023-01-01",{"date":104,"type":85},"2026-03-30",{"name":5,"class":6},1]